I think the Aspire and Aruda shares were long since absorbed. I do not think that any selling from them is why the share price is low. Rather, every time the share price has started recovering, there has been a Mako attack, or a Rosen BS lawsuit, often at "coincidentally" the same time as an AF tweet.

There is no way that the selling of even millions of shares over two years accounts for this share price. The market cap is less than that of pre-clinical companies with only one class of drug in development, rather than 3 different drugs with multiple applications that are in thus-far successful clinical trials.

Having watched the tape go by on many occasions, it is clear that there has been a pattern of manipulation of stock price. Because the behavior of the trades during the day has suddenly changed, I think that there has been considerable short covering, and that the stock is poised for a move up. Also, the appearance of former bashers now attempting to pump the stock, or claiming always to have been bullish, indicates that at least one of the small-traders' gangs has changed sides.

In any case, I have utter confidence in the science, and I believe that when the move upward comes (which I don't expect until the fall, but of course I know nothing more than any other investor does), it will be shocking in its magnitude. Hopefully it will destroy any remaining short sellers when it does.